150 related articles for article (PubMed ID: 7522939)
21. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
[TBL] [Abstract][Full Text] [Related]
22. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
23. Detection of prostate cancer in males with prostatism.
Lepor H; Owens RS; Rogenes V; Kuhn E
Prostate; 1994 Sep; 25(3):132-40. PubMed ID: 7520577
[TBL] [Abstract][Full Text] [Related]
24. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
[TBL] [Abstract][Full Text] [Related]
25. Early diagnosis of prostate cancer in the Western Cape.
Heyns CF; Naudé AM; Visser AJ; Marais DC; Stopforth HB; Nyarko JK; Stellmacher GA
S Afr Med J; 2001 Aug; 91(8):679-84. PubMed ID: 11584784
[TBL] [Abstract][Full Text] [Related]
26. Relative contribution of digital rectal examination and transrectal ultrasonography in interpreting serum prostate-specific antigen values for screening prostate cancer in Arab men.
Sheikh M; Sinan T; Kehinde EO; Hussein AY; Anim JT; Al-Hunayan AA
Ann Saudi Med; 2007; 27(2):73-8. PubMed ID: 17356323
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of transrectal ultrasound guided biopsy in patients over 70 years old with a prostate specific Antigen (PSA) level ≤ 15 ng/ml and normal digital rectal examination: a 10-year prospective follow-up study of 427 consecutive patients.
Mohamed ZK; Dominguez-Escrig J; Vasdev N; Bharathan B; Greene D
Urol Oncol; 2013 Nov; 31(8):1489-96. PubMed ID: 22591749
[TBL] [Abstract][Full Text] [Related]
28. Association between literacy, compliance with prostate cancer screening, and cancer aggressiveness: results from a Brazilian screening study.
Tobias-Machado M; Carvalhal GF; Freitas CH; Reis RB; Reis LO; Nogueira L; Machado RD; Magnabosco W; Vieira RA; Mauad EC; Carvalho AL; Faria EF;
Int Braz J Urol; 2013; 39(3):328-34. PubMed ID: 23849582
[TBL] [Abstract][Full Text] [Related]
29. Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.
Schröder FH; Roobol-Bouts M; Vis AN; van der Kwast T; Kranse R
Urology; 2001 Jan; 57(1):83-90. PubMed ID: 11164149
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels.
Roehrborn CG; Pickens GJ; Sanders JS
Urology; 1996 Mar; 47(3):347-52. PubMed ID: 8633400
[TBL] [Abstract][Full Text] [Related]
31. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
32. Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer.
Heman-Ackah CA; Festenstein JB; Hibbert P; Harvey DJ; Bunce CJ; Gelister JS
Br J Urol; 1997 Mar; 79(3):439-44. PubMed ID: 9117228
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less.
Yamamoto T; Ito K; Ohi M; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
Urology; 2001 Dec; 58(6):994-8. PubMed ID: 11744475
[TBL] [Abstract][Full Text] [Related]
34. Clinical usefulness of free PSA in early detection of prostate cancer.
Luboldt HJ; Swoboda A; Börgermann C; Fornara P; Rübben H;
Onkologie; 2001 Feb; 24(1):33-7. PubMed ID: 11441278
[TBL] [Abstract][Full Text] [Related]
35. Screening for prostate cancer.
Pode D; Shapiro A; Lebensart P; Meretyk S; Katz G; Barak V
Isr J Med Sci; 1995; 31(2-3):125-8. PubMed ID: 7538101
[TBL] [Abstract][Full Text] [Related]
36. Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.
Pinsky PF; Andriole GL; Kramer BS; Hayes RB; Prorok PC; Gohagan JK;
J Urol; 2005 Mar; 173(3):746-50; discussion 750-1. PubMed ID: 15711261
[TBL] [Abstract][Full Text] [Related]
37. Prostate carcinoma screening in the county of Tyrol, Austria: experience and results.
Reissigl A; Horninger W; Fink K; Klocker H; Bartsch G
Cancer; 1997 Nov; 80(9):1818-29. PubMed ID: 9351555
[TBL] [Abstract][Full Text] [Related]
38. Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial.
Pinsky PF; Crawford ED; Kramer BS; Andriole GL; Gelmann EP; Grubb R; Greenlee R; Gohagan JK
BJU Int; 2007 Apr; 99(4):775-9. PubMed ID: 17223921
[TBL] [Abstract][Full Text] [Related]
39. Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.
Eastham JA; May R; Robertson JL; Sartor O; Kattan MW
Urology; 1999 Oct; 54(4):709-13. PubMed ID: 10510933
[TBL] [Abstract][Full Text] [Related]
40. [Yield of ultrasound-guided transrectal biopsy in the diagnosis of prostatic cancer in symptomatic patients].
Herranz Amo F; Verdú Tartajo F; Díez Cordero JM; Sáiz Carrero A; Lledó García E; Rodríguez Fernández E; Bueno Chomón G
Arch Esp Urol; 1997 Apr; 50(3):283-8. PubMed ID: 9265452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]